» Articles » PMID: 20015409

Microbial Community Analysis Reveals High Level Phylogenetic Alterations in the Overall Gastrointestinal Microbiota of Diarrhoea-predominant Irritable Bowel Syndrome Sufferers

Overview
Publisher Biomed Central
Specialty Gastroenterology
Date 2009 Dec 18
PMID 20015409
Citations 160
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A growing amount of scientific evidence suggests that microbes are involved in the aetiology of irritable bowel syndrome (IBS), and the gastrointestinal (GI) microbiota of individuals suffering from diarrhoea-predominant IBS (IBS-D) is distinguishable from other IBS-subtypes. In our study, the GI microbiota of IBS-D patients was evaluated and compared with healthy controls (HC) by using a high-resolution sequencing method. The method allowed microbial community analysis on all levels of microbial genomic guanine plus cytosine (G+C) content, including high G+C bacteria.

Methods: The collective faecal microbiota composition of ten IBS-D patients was analysed by examining sequences obtained using percent G+C (%G+C) -based profiling and fractioning combined with 16S rRNA gene clone library sequencing of 3267 clones. The IBS-D library was compared with an analogous healthy-control library of 23 subjects. Real-time PCR analysis was used to identify phylotypes belonging to the class Gammaproteobacteria and the order Coriobacteriales.

Results: Significant differences were found between clone libraries of IBS-D patients and controls. The microbial communities of IBS-D patients were enriched in Proteobacteria and Firmicutes, but reduced in the number of Actinobacteria and Bacteroidetes compared to control. In particular, 16S rDNA sequences belonging to the family Lachnospiraceae within the phylum Firmicutes were in greater abundance in the IBS-D clone library.

Conclusions: In the microbiota of IBS-D sufferers, notable differences were detected among the prominent bacterial phyla (Firmicutes, Actinobacteria, Bacteroidetes, and Proteobacteria) localized within the GI tract.

Citing Articles

Association of body roundness index with chronic diarrhea and constipation, NHANES 2005-2010.

Zhuang Y, Li L, Sun J, Zhang Y, Dai F J Health Popul Nutr. 2025; 44(1):50.

PMID: 40022226 PMC: 11869572. DOI: 10.1186/s41043-025-00793-7.


Perspectives on Berberine and the Regulation of Gut Microbiota: As an Anti-Inflammatory Agent.

Jael Teresa de Jesus Q, Galvez-Ruiz J, Marquez Ibarra A, Leyva-Peralta M Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006007 PMC: 11858814. DOI: 10.3390/ph18020193.


Gut microbial dysbiosis associated to diarrheic irritable bowel syndrome can be efficiently simulated in the Mucosal ARtificial COLon (M-ARCOL).

Uriot O, Deschamps C, Scanzi J, Brun M, Kerckhove N, Duale C Bioengineered. 2025; 16(1):2458362.

PMID: 39902883 PMC: 11796540. DOI: 10.1080/21655979.2025.2458362.


Exploring Gut Microbiota Imbalance in Irritable Bowel Syndrome: Potential Therapeutic Effects of Probiotics and Their Metabolites.

Garcia Mansilla M, Rodriguez Sojo M, Lista A, Ayala Mosqueda C, Ruiz Malagon A, Galvez J Nutrients. 2025; 17(1.

PMID: 39796588 PMC: 11723002. DOI: 10.3390/nu17010155.


Meta-analysis of gut microbiota alterations in patients with irritable bowel syndrome.

Li X, Li X, Xiao H, Xu J, He J, Xiao C Front Microbiol. 2025; 15():1492349.

PMID: 39777150 PMC: 11703917. DOI: 10.3389/fmicb.2024.1492349.


References
1.
Roka R, Rosztoczy A, Leveque M, Izbeki F, Nagy F, Molnar T . A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol. 2007; 5(5):550-5. DOI: 10.1016/j.cgh.2006.12.004. View

2.
Kassinen A, Krogius-Kurikka L, Makivuokko H, Rinttila T, Paulin L, Corander J . The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology. 2007; 133(1):24-33. DOI: 10.1053/j.gastro.2007.04.005. View

3.
Si J, Yu Y, Fan Y, Chen S . Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol. 2004; 10(12):1802-5. PMC: 4572273. DOI: 10.3748/wjg.v10.i12.1802. View

4.
Dunlop S, Hebden J, Campbell E, Naesdal J, Olbe L, Perkins A . Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol. 2006; 101(6):1288-94. DOI: 10.1111/j.1572-0241.2006.00672.x. View

5.
Ohman L, Simren M . New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig Liver Dis. 2007; 39(3):201-15. DOI: 10.1016/j.dld.2006.10.014. View